Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy adults: a randomized, double-blind, placebo-controlled clinical trial

Elaine Patterson,Hern Tze Tina Tan,David Groeger,Mark Andrews,Martin Buckley,Eileen F. Murphy,John A. Groeger
DOI: https://doi.org/10.1038/s41598-024-53810-w
IF: 4.6
2024-02-16
Scientific Reports
Abstract:Stress and sleep are linked with overall well-being. Bifidobacterium longum 1714 has been shown to influence stress responses and modulate neural responses during social stress, and influence sleep quality during examination stress in healthy adults. Here, we explored the ability of this strain to alter sleep quality in adults using subjective and objective measures. Eighty-nine adults (18–45y) with impaired sleep quality assessed with the Pittsburgh Sleep Quality Index (PSQI) and with a global score ≥ 5 were randomized to receive B. longum 1714 or placebo daily for eight weeks. Assessing the effect of the strain on PSQI global score was the primary objective. Secondary objectives assessed sleep quality and well-being subjectively and sleep parameters using actigraphy objectively. While PSQI global score improved in both groups, B. longum 1714 significantly improved the PSQI component of sleep quality ( p < 0.05) and daytime dysfunction due to sleepiness ( p < 0.05) after 4 weeks and social functioning ( p < 0.05) and energy/vitality ( p < 0.05) after 8 weeks, compared to placebo. No significant effect on actigraphy measures were observed. The 1714 strain had a mild effect on sleep, demonstrated by a faster improvement in sleep quality at week 4 compared to placebo, although overall improvements after 8 weeks were similar in both groups. B. longum 1714 improved social functioning and increased energy/vitality in line with previous work that showed the strain modulated neural activity which correlated with enhanced vitality/reduced mental fatigue (ClinicalTrials.gov: NCT04167475).
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore whether a specific probiotic strain, **Bifidobacterium longum 1714**, can improve sleep quality and enhance the quality of life of healthy adults. Specifically, the study aims to evaluate the impact of this probiotic on sleep quality in terms of subjective and objective indicators, and whether it can improve daytime dysfunction caused by lack of sleep and other aspects related to the quality of life. ### Research Background - **The Relationship between Stress and Sleep**: Stress and sleep quality are closely related to overall health. Previous studies have shown that **Bifidobacterium longum 1714** can affect the stress response, regulate the neural response during social stress, and improve sleep quality during exam stress. - **The Role of the Gut Microbiota**: In recent years, more and more evidence has shown that the gut microbiota plays an important role in brain development, function, and emotional health. Changes in the gut microbiota may affect sleep quality through immune, metabolic, and nervous system regulation. - **The Potential of Probiotics**: Some studies have shown that specific probiotics (such as lactic acid bacteria and bifidobacteria) can improve the sleep quality of healthy adults. However, the results of these studies are not consistent and need further verification. ### Research Objectives - **Primary Objective**: Evaluate the impact of **Bifidobacterium longum 1714** on the global score of the **Pittsburgh Sleep Quality Index (PSQI)**. - **Secondary Objective**: Evaluate the subjective and objective impacts of **Bifidobacterium longum 1714** on sleep quality, daytime dysfunction, social function, energy/vitality, etc. ### Research Design - **Experimental Design**: This is a randomized, double - blind, placebo - controlled clinical trial. A total of 89 adults aged 18 to 45 participated. They were randomly assigned to the **Bifidobacterium longum 1714** group or the placebo group, taking it once a day for 8 weeks. - **Evaluation Methods**: - **Subjective Evaluation**: Use the **PSQI** to evaluate sleep quality, use the **Epworth Sleepiness Scale (ESS)** to evaluate the degree of daytime sleepiness, and use the **Short Form Health Survey - 36 (SF - 36)** to evaluate overall health status. - **Objective Evaluation**: Use **actigraphy** to objectively evaluate sleep parameters, including sleep duration, sleep latency, sleep efficiency, number of awakenings, etc. ### Main Findings - **PSQI Global Score**: Although the **PSQI** global scores of both groups improved, the **Bifidobacterium longum 1714** group significantly improved the sleep quality component of the **PSQI** (\( p < 0.05 \)) and daytime dysfunction caused by sleepiness (\( p < 0.05 \)) at 4 weeks. - **Other Aspects**: At 8 weeks, the social function (\( p < 0.05 \)) and energy/vitality (\( p < 0.05 \)) of the **Bifidobacterium longum 1714** group also significantly improved. - **Objective Evaluation**: There were no significant changes in the **actigraphy** indicators. ### Conclusions - **Bifidobacterium longum 1714** can improve sleep quality to a certain extent, especially showing a faster improvement effect at 4 weeks. In addition, this strain can also improve social function and increase energy/vitality, but has no significant impact on objective sleep parameters measured by **actigraphy**. This study provides new evidence for the potential application of **Bifidobacterium longum 1714** in improving sleep quality and enhancing the quality of life.